• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Unichem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 577.0
  • ISIN : INE351A01035
607.40 -16 (-2.57%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    602.75

  • Today’s High

    629.70

  • Open

    629.70

  • Perv Close

    623.45

  • 52W Low

    533.30

  • 52W High

    937.95

Key Indicators

  • P/E(TTM)

    27.02

  • Mar.Cap (₹Cr.)

    4,276.45

  • Div & Yield %

    0.00

  • Book Value(₹)

    349.37

  • Debt-Equity Ratio

    -2.57

  • AGM Date

    01-Aug-2025

  • EPS

    22.52

  • P/E Ratio

    27.02

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    4,276.45

  • RONW (%)

    -1.79

  • ROCE (%)

    -0.23

Score Board

  • Equity (₹ in Cr.)

    14.08

  • BV (₹)

    349.40

  • Sales( ₹ in Cr.)

    1,735.70

  • NP (in Cr.)

    158.54

  • NP Var(%)

    537.0

  • Div%

    0.0

  • CPS (₹)

    37.90

  • EPS (₹)

    22.50

  • Traded Value (₹ in Lakhs)

    4,283.84

  • 52 Week High

    937.95

  • 52 Week Low

    533.30

  • Price BSE

    608.0

  • Price NSE

    607.00

  • Market Capital( in Cr.)

    4,283.84

  • P/C Ratio

    16.00

  • P/E Ratio

    27.00

  • Price Vs.BV

    22.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,735.70 1,442.16 1,072.43 942.93 1,123.97 904.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,735.70 1,442.16 1,072.43 942.93 1,123.97 904.44
Other Income 44.83 98.40 41.85 42.07 47.37 99.17
Stock Adjustments 33.33 26.35 -22.01 52.79 16.73 18.50
Total Income 1,813.86 1,566.91 1,092.27 1,037.79 1,188.07 1,022.11
EXPENDITURE :            
Raw Materials 830.62 717.82 501.86 436.27 449.67 401.25
Power and Fuel Cost 106.63 105.64 101.41 77.12 67.95 72.14
Employee Cost 287.51 283.15 270.86 250.79 234.04 205.16
Other Manufacturing Expenses 78.10 74.62 70.61 73.49 64.48 68.09
Selling and Administration Expenses 190.81 213.59 194.89 192.65 225.80 263.43
Miscellaneous Expenses 21.48 148.40 116.36 8.95 3.28 3.48
Employee Benefit Expenses 287.51 283.15 270.86 250.79 234.04 205.16
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,515.15 1,543.22 1,256.00 1,039.27 1,045.23 1,013.55
Operating Profit 298.71 23.69 -163.73 -1.49 142.84 8.56
Interest 7.62 10.42 9.38 2.07 1.30 1.28
Gross Profit 291.09 13.27 -173.11 -3.56 141.54 7.28
Depreciation 108.41 105.45 105.98 83.19 75.89 71.09
Profit Before Tax 182.68 -92.18 -279.09 -86.75 65.65 -63.81
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 19.72 0.00 20.61 -31.32 11.56 -7.50
Reported Net Profit 162.96 -92.18 -299.70 -55.43 54.08 -56.32
Extraordinary Items 4.42 -55.94 -103.16 -0.25 0.02 -1.45
Adjusted Net Profit 158.54 -36.24 -196.54 -55.18 54.06 -54.87
Adjustment below Net Profit 0.00 0.00 121.81 0.00 0.00 0.00
P & L Balance brought forward 2,279.18 2,359.31 2,565.36 2,648.96 2,623.04 2,712.21
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -2.89 -12.05 28.16 28.16 28.16 32.85
P & L Balance carried down 2,445.03 2,279.18 2,359.31 2,565.36 2,648.96 2,623.04
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 200.00 200.00 200.00 200.00
Dividend Per Share(Rs) 0.00 0.00 4.00 4.00 4.00 4.00
Earnings Per Share-Unit Curr 23.15 -13.09 -42.57 -7.87 7.68 -8.00
Earnings Per Share(Adj)-Unit Curr 23.15 -13.09 -42.57 -7.87 7.68 -8.00
Book Value 349.40 325.94 338.65 379.52 383.11 375.99
Book Value(Adj)-Unit Curr 349.40 325.94 338.65 379.52 383.11 375.99

Shareholding Pattern

  • Promoter Group

    70.22%

  • Public Share Holding

    29.78%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 37,081,011 52.67 37,081,011 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,221,224 17.36 12,221,224 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 138,351 0.20 138,351 3
Others 0 0.00 0 0
Sub Total 49,440,586 70.22 49,440,586 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 22,954 0.03 22,454 4
Foreign Bank 500 0.00 500 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 690,506 0.98 690,006 38
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 153,628 0.22 153,628 2
Mutual Funds / UTI 6,607,710 9.39 6,607,710 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 900,882 1.28 900,882 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,376,180 11.90 8,375,180 53
2] Non Institution
Bodies Corporate 271,989 0.39 271,909 157
Clearing Members 30 0.00 30 2
Directors of their Relatives 1 0.00 1 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 450,293 0.64 448,293 511
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 377,970 0.54 377,970 685
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,288,169 1.83 620,044 5
Individuals holding nominal share capital up to Rs. 1 lakh 9,387,548 13.33 8,626,021 21,574
Market Maker 2 0.00 2 1
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 744,892 1.06 744,892 1
Sub Total 12,588,984 17.88 11,157,252 22,949
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 70,405,750 100.00 68,973,018 23,010

Company Background

Unichem Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Unichem Laboratories Ltd
  • BSE Code : 577.0
  • ISIN : INE351A01035

  • Incorporation Year

    1962

  • Registered Office

    Unichem Bhavan Prabhat Estate
    Off S V Road Jogeshwari (West), Mumbai,
    Maharashtra-400102

  • Telephone

    91-22-66888333

  • FAX

    91-22-26784391

  • Chairman

    Prakash A Mody

  • Managing Director

    Pabitra Bhattacharya

  • Company Secretary

    Pradeep Bhandari

  • Auditor

    N A Shah Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Unichem Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Unichem Labs. 608.45 1,776.53 1,735.70 26.28 7.58
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10